Effect of Plant vs Animal Protein Supplementation on Body Composition in Youth Soccer Players
PLANT-ANIMAL-P
A Prospective, Single-Blind, Randomized Controlled Trial Comparing Plant-Based and Animal-Based Protein Supplementation Effects on Body Composition and Lean Mass in Elite Male Youth Soccer Players: A 4-Week Intervention Study
1 other identifier
interventional
25
1 country
1
Brief Summary
This prospective, single-blind, randomized controlled trial investigates the comparative effects of plant-based protein (soy and rice blend) versus animal-based protein (whey) supplementation on body composition parameters in elite male youth soccer players. Twenty-five players (ages 16-18.7 years) from Udinese Calcio's Primavera (U-19) category are randomized into three groups: Plant Protein Group (n=8), Animal Protein Group (n=9), and Placebo Group (n=8). The intervention consists of post-training protein supplementation (17g protein/dose) administered within 15-30 minutes after each training session over a 4-week microcycle during the competitive season. Body composition is assessed using a multi-compartmental model including anthropometry (ISAK protocol), bioelectrical impedance analysis (BIA), and dual-energy X-ray absorptiometry (DEXA).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 17, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 18, 2026
CompletedFirst Submitted
Initial submission to the registry
March 8, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
March 30, 2026
CompletedFirst Posted
Study publicly available on registry
May 6, 2026
CompletedMay 6, 2026
May 1, 2026
1 month
March 8, 2026
May 2, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Fat-Free Mass (Lean Body Mass)
Change in fat-free mass (kg) from baseline to week 4, assessed using a multi-compartmental model combining bioelectrical impedance analysis (BIA), anthropometry according to ISAK protocol, and dual-energy X-ray absorptiometry (DEXA). Fat-free mass represents total body mass minus fat mass.
Baseline (Week 0) and Final Assessment (Week 4)
Secondary Outcomes (7)
Change in Body Fat Percentage
Baseline (Week 0) and Final Assessment (Week 4)
Change in Total Body Mass
Baseline (Week 0) and Final Assessment (Week 4)
Change in Total Lean Mass by DEXA
Baseline (Week 0) and Final Assessment (Week 4)
Change in Sum of Skinfolds
Baseline (Week 0) and Final Assessment (Week 4)
Change in Limb Circumferences
Baseline (Week 0) and Final Assessment (Week 4)
- +2 more secondary outcomes
Study Arms (3)
Plant Protein Group
EXPERIMENTALParticipants receive plant-based protein supplementation (17.4g protein per dose) consisting of 330ml soy beverage and 22g plant-based protein powder, administered within 15-30 minutes post-training under direct supervision for 4 weeks during competitive season.
Animal Protein Group
ACTIVE COMPARATORParticipants receive animal-based protein supplementation (17.3g protein per dose) consisting of 200ml rice beverage and 33g whey protein powder blend, administered within 15-30 minutes post-training under direct supervision for 4 weeks during competitive season.
Placebo Group
PLACEBO COMPARATORParticipants receive placebo supplementation (0.2g protein per dose) consisting of 200ml rice beverage and vanilla flavoring, administered within 15-30 minutes post-training under direct supervision for 4 weeks during competitive season. Appearance and delivery identical to active interventions.
Interventions
Composition per dose: 200ml rice beverage (0.2g protein) + 22g neutral whey protein (12.0g protein) + 11g vanilla whey protein (5.1g protein) = 17.3g total protein. Administered post-training (15-30 min after), prepared 8 hours before, stored at 4°C, supervised consumption verified by nutrition staff.
Composition per dose: 200ml rice beverage (0.2g protein) + vanilla flavoring = 0.2g total protein. Administered post-training (15-30 min after), prepared 8 hours before, stored at 4°C, supervised consumption verified by nutrition staff. Identical appearance to active supplements to maintain blinding.
Composition per dose: 330ml soy beverage (10.8g protein) + 22g plant protein powder (6.6g protein) = 17.4g total protein. Administered post-training (15-30 min after), prepared 8 hours before, stored at 4°C, supervised consumption verified by nutrition staff.
Eligibility Criteria
You may qualify if:
- Active contract with Udinese Calcio's Primavera (U-19) category during the 2025-2026 season
- Regular participation in the team's technical-tactical and strength training program (minimum 4 sessions per week)
- Signed informed consent (parental consent for participants under 18 years)
- Commitment to adhere to measurement protocol requiring 8-hour fast and assessment at 07:00h
- Commitment to adhere to post-training supplementation protocol with administration at 17:00h
- Confirmed presence and availability for both baseline assessment (Week 0) and final assessment (Week 4)
You may not qualify if:
- Open injury records or currently in functional readaptation phase at study initiation
- Consumption of ergogenic or nutritional supplementation independently and external to the club-supervised protocol during the 4 weeks prior to study or during the study period
- Previous diagnosis or current symptomatology compatible with eating disorders
- Known allergies or intolerances to soy, rice, dairy-based proteins, or vanilla flavoring
- Current use of medications that may affect body composition or protein metabolism (anabolic steroids, growth hormone, corticosteroids, thyroid hormones)
- Diagnosed chronic diseases that may affect protein metabolism or body composition (diabetes mellitus, chronic kidney disease, liver disease, malabsorption syndromes)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Antonio Molina Lopezlead
- Universidad Europea de Madridcollaborator
- Universidad Pablo de Olavidecollaborator
Study Sites (1)
Udinese Calcio
Udine, Udine, 33100, Italy
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Antonio Blas Molina Lopez, Phd
CTS-595 Research Group, Centre for Research into Physical and Sporting Performance. Universidad Pablo de Olavide
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Masking Details
- Participants are blinded to group assignment and the existence of three distinct intervention groups. All supplements are prepared and delivered in identical containers. Nutrition staff administering supplements are not blinded (necessary for proper preparation).
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Investigator, PhD, CTS-595 Research Group, Centre for Research into Physical and Sporting Performance Affiliation: Universidad Pablo de Olavide
Study Record Dates
First Submitted
March 8, 2026
First Posted
May 6, 2026
Study Start
January 17, 2026
Primary Completion
February 18, 2026
Study Completion
March 30, 2026
Last Updated
May 6, 2026
Record last verified: 2026-05
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP
- Time Frame
- Individual participant data will be available immediately following publication of the primary manuscript and will remain available for at least 5 years. Supporting documents (study protocol and statistical analysis plan) will be available indefinitely.
- Access Criteria
- De-identified individual participant data will be shared with researchers who provide a methodologically sound proposal for academic purposes. Requests should be directed to the corresponding author at antoniomolina@centrosnutrifarma.es. Requestors will need to sign a data access agreement and specify the intended use of the data. Data will be provided in anonymized CSV format via secure file transfer within 30 days of approval.